Natco Pharma Ltd

NSE: NATCOPHARM · BSE: 524816 · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹839.30
Market cap: ₹15,033 Cr
Revenue (annual): ₹4,078 Cr
Net profit (annual): ₹1,418 Cr
P/E (TTM): 13.1×Sector 50.4×
Promoter holding: 49.42%+0.00% QoQ
FII holding: 16.99%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 Capital Structure Change 3 Fund Raise 2 Board Meeting Date 2 Other Announcement 1 Financial Results 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

25 Sep 2026 11:17 IST NSE

Capital Structure Change

Natco Pharma Capital Structure Change

Natco Pharma's board approved a Rights Issue of 1,70,58,082 shares aggregating to ₹1,279.36 Crore. The issue is priced at ₹750 per share with a 2:21 ratio.

Value: ₹1,279 Cr

Read the filing ↗

21 Sep 2026 22:44 IST BSE

Capital Structure Change

Natco Pharma Capital Structure Change

Natco Pharma has received in-principle approval from BSE and NSE for its upcoming Rights Issue of fully paid-up equity shares.

Read the filing ↗

9 Sep 2026 17:49 IST NSE

Capital Structure Change

Natco Pharma Capital Structure Change

Natco Pharma proposes a Rights Issue of equity shares aggregating up to ₹1,300 Crore. The company has filed the Draft Letter of Offer for this capital raise.

Value: ₹1,300 Cr

Read the filing ↗